Comment on “Open vs robotic gastrectomy with D2 lymphadenectomy: a propensity score-matched analysis on 1469 patients from the IMIGASTRIC prospective database”

Author:

Graziosi Luigina,Natalizi Nicola,Donini Annibale

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Reference6 articles.

1. Trastulli S, Desiderio J, Lin JX, Reim D, Zheng CH, Borghi F, Cianchi F, Norero E, Nguyen NT, Qi F, Coratti A, Cesari M, Bazzocchi F, Alimoglu O, Brower ST, Pernazza G, D’Imporzano S, Azagra JS, Zhou YB, Cao SG, Guerra F, Liu T, Arcuri G, González P, Staderini F, Marano A, Di Nardo D, Parisi A, Huang CM, Tebala GD (2023) Open vs robotic gastrectomy with D2 lymphadenectomy: a propensity score-matched analysis on 1469 patients from the IMIGASTRIC prospective database. Langenbecks Arch Surg 408(1):302. https://doi.org/10.1007/s00423-023-03032-x

2. Van Der Werf LR, Wijnhoven BPL, Fransen LFC, Van Sandick JW, Nieuwenhuijzen GAP, Busweiler LAD et al (2019) A national cohort study evaluating the association between short-term outcomes and long-term survival after esophageal and gastric cancer surgery. Ann Surg 270(5):868–876

3. de Jongh C, Triemstra L, van der Veen A, Brosens LAA, Nieuwenhuijzen GAP, Stoot JHMB, de Steur WO, Ruurda JP, van Hillegersberg R, Brenkman HJF, Seesing MFJ, Luyer MDP, Ponten JEH, Tegels JJW, Hulsewe KWE, Hartgrink HH, Wijnhoven BPL, Lagarde SM, Kouwenhoven EA, van Det MJ, Wassenaar EB, van Duijvendijk P, Draaisma WA, Broeders IAMJ, van der Peet DL, Gisbertz SS (2023) Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial. Eur J Surg Oncol 49(10):107018. ISSN 0748–7983

4. Lordick F et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):1005–1020

5. Cui H, Zhang KC, Cao B, Deng H, Liu GB, Song LQ, Zhao RY, Liu Y, Chen L, Wei B (2022) Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy. World J Gastrointest Surg 14(5):452–469

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3